Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, RS Large Cap Val Strategy. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+5.03%
YTD+6.03%
Annualized+12.05%
Positioning StanceNEUTRAL
Market CapLarge Cap
GeographyUS
Digest Analysis
Quick Take
"RS Large Cap Value underperformed in Q2 2026.87% for the Russell 1000 Value Index. Market leadership shifted from hyperscalers to AI infrastructure providers."
Executive Summary
The RS Large Cap Value Strategy underperformed its Russell 1000 Value Index benchmark in Q2 2026, returning 5.03% net versus 13.87% for the index. The S&P 500 rallied 15% during the quarter despite ongoing uncertainties including the Iran conflict, elevated inflation, and Federal Reserve leadership changes. Market leadership shifted from the Magnificent Seven hyperscalers to AI infrastructure providers including semiconductors, memory, and power generators, driving strong performance in Industrials and Energy sectors. Small cap stocks outperformed large caps as investors moved down the cap spectrum. The strategy's underperformance was driven by unfavorable stock selection in Information Technology and Industrials, partially offset by positive selection in Communication Services, Consumer Staples, and Energy. The team maintains its ROIC-focused approach, seeking companies with sound balance sheets, improving fundamentals, and stock prices trading at deep discounts to intrinsic value. Key holdings include CVS Health, which is recovering from Medicare Advantage margin compression, and MarketAxess, where the team remains positive on structural change opportunities. Looking ahead, the team continues to prioritize businesses with improving ROIC and strong balance sheets while maintaining strict valuation discipline and a margin of safety approach.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
58%
CautiousHigh
Moderate (58%)
The strategy holds a diversified portfolio of large cap value stocks with 12 named positions in the top contributors/detractors tables, suggesting 20-30+ total holdings. Two positions (CVS and MKTX) receive detailed thesis discussion with specific metrics and catalysts. The manager uses moderately strong language about their process and approach but hedges with phrases like 'we believe' and 'we perceive.' CVS was trimmed opportunistically despite positive view, and MKTX is held despite underperformance, showing conviction but not extreme concentration. The emphasis on ROIC and valuation discipline is clear, but the diversified nature of the portfolio and hedged language caps conviction in the moderate range.
Growth Outlook
50%
BearishBullish
Neutral (50%)
The manager describes the market as resilient with the S&P 500 rallying 15% in Q2 and registering new all-time highs more than 20 times during the year. They note investor sentiment has become more constructive with signs of improving economic activity driven by reshoring, electrification, infrastructure spending, and deregulation. However, they acknowledge ongoing concerns including elevated inflation, lackluster labor market, and fragile geopolitical situation. The tone is cautiously optimistic, acknowledging both opportunities and risks. The phrase 'more constructive but still uncertain environment' captures the balanced view.
Risk Appetite
25%
DefensiveAggressive
Defensive (25%)
The portfolio is fully invested in equities as a large cap value strategy, but the manager emphasizes risk management and strict valuation discipline. They trimmed CVS opportunistically to fund other ideas, suggesting active portfolio management rather than aggressive deployment. The underweight in Information Technology (which hurt performance) indicates selective positioning rather than maximum risk-on exposure. The emphasis on 'margin of safety' and 'risk management remain vital' suggests a measured rather than aggressive risk posture.
Capital Deployment
5%
De-riskingDeploying
De-risking (5%)
No cash level data is provided in the letter. The manager trimmed CVS to fund other attractive ideas, indicating capital rotation rather than net deployment or de-risking. This is a reallocation within the portfolio, not a change in overall exposure. The phrase 'fund other attractive ideas' suggests the proceeds were reinvested, keeping net exposure stable. With no evidence of cash level changes and only rotation activity described, the score reflects neutral positioning with slight positive bias for the rotation into new ideas.
Forward Guidance
35%
CautiousExpansionary
Cautious (35%)
The manager states they continue to prioritize businesses with improving ROIC and strong balance sheets while maintaining disciplined valuation approach. The language 'continue to' suggests steady-state positioning rather than active deployment. They trimmed CVS to fund other ideas, indicating selective rotation rather than net deployment. The emphasis on 'it's far better to focus on the long-term business prospects' rather than 'short-term machinations' suggests a patient, monitoring stance. No explicit language about deploying cash or scaling positions aggressively.
Language Signal
40%
BearishBullish
Balanced (40%)
Bullish language includes: resilient, rally, constructive, improving economic activity, strong performance, robust returns, attractive risk-adjusted returns, credible path to earnings increase. Bearish/cautious language includes: uncertainties, impediment, concern, headwinds, fragile, lingering questions, tricky environment, risk management vital, caution warranted. The letter uses more constructive language overall, particularly around market performance and economic activity, but balances this with meaningful risk acknowledgment. The net balance tilts mildly positive but is notably balanced.
Perceived Risk
55%
Low RiskElevated
Moderate Risk (55%)
The manager identifies several specific risks with meaningful discussion: elevated inflation and its impact on interest rates, lackluster labor market, fragile Iran ceasefire with risk of renewed escalation, Federal Reserve leadership change and focus shift to price stability, and rising valuations. The phrase 'tricky environment' and emphasis that 'risk management and strict valuation discipline remain vital' indicate moderate risk awareness. However, the risks are discussed as manageable concerns rather than systemic threats. The manager does not express alarm or predict crisis, but clearly acknowledges multiple identifiable risks that warrant caution.
Opportunity Density
60%
ScarceAbundant
Selective (60%)
The manager describes trimming CVS to fund 'other attractive ideas within the portfolio,' indicating they are finding selective opportunities. They discuss two positions in detail (CVS and MKTX) with specific theses and catalysts. The emphasis on 'focus on the long-term business prospects of individual companies' and seeking 'companies with sound balance sheets, solid fundamentals, improving ROIC, and stock prices trading at what we perceive as a deep discount to intrinsic value' suggests they are finding opportunities that meet their criteria. However, the emphasis on selectivity, strict valuation discipline, and margin of safety indicates opportunities are not abundant across the board, but rather require careful selection.
Time Horizon
70%
Short-TermLong-Term
Decade+ (70%)
The manager explicitly states they are 'long-term investors who use our investment time horizon as a key differentiator.' They emphasize focusing on 'long-term business prospects' rather than 'short-term machinations of the market' and describe their approach as pursuing 'attractive risk-adjusted returns over longer time periods.' For CVS, they describe 'a credible path to an earnings increase over the next two to three years,' indicating a multi-year thesis. The emphasis on ROIC improvement 'over longer periods of time' and management teams that can 'navigate through short-term market volatility and appear to be poised to deliver long-term shareholder value' reinforces a multi-year horizon. However, this is a public equities fund with quarterly reporting, not permanent capital, so the score reflects a strong but not extreme long-term orientation.